Uniwersytecki Szpital Kliniczny W Białymstoku
Białystok, Poland
Treatment & access
- Treatments offeredEsketamine nasal spray (Spravato®)
- Access routeCovered by a national programme
- Cost & coverage (registry status)Covered by NFZ (drug programme B.147)
- ReimbursementNFZ drug programme B.147 - leczenie chorych na depresję lekooporną How reimbursement works in Europe →
- Phone+48 85 831 73 17
- Websitehttps://uskwb.pl/
Related listings
These records belong to the same organisation. They are listed separately because each is a distinct programme or location.
- Another programme at this clinicUniwersytecki Szpital Kliniczny W Białymstoku : Clinical trials
About this provider
The University Clinical Hospital in Białystok (Uniwersytecki Szpital Kliniczny w Białymstoku) is the teaching hospital of the Medical University of Białystok. Per NFZ data it provides esketamine (Spravato) treatment for treatment-resistant depression under the fully funded NFZ drug program B.147. Its Psychiatry Clinic at ul. Wołodyjowskiego 2, led by Prof. Napoleon Waszkiewicz, works with medical, nursing and psychologist/therapist teams, and the same site houses a Mental Health Centre (Centrum Zdrowia Psychicznego) with its own registration line.
Services & programs
- Psychiatry Clinic (Klinika Psychiatrii) at ul. Wołodyjowskiego 2, inpatient university psychiatry
- Mental Health Centre (Centrum Zdrowia Psychicznego) with dedicated registration
- Psychologists and occupational therapists within the clinic team
- NFZ drug program B.147, esketamine for treatment-resistant depression (per NFZ data)
Common questions
How do I start esketamine treatment at this hospital?
You need a referral from a psychiatrist. Qualification follows the B.147 program criteria: age 18-75, a moderate or severe episode of treatment-resistant depression after at least two adequately dosed antidepressants. Contact the Psychiatry Clinic (tel. 85 831 73 17) or the Mental Health Centre registration (85 831 73 15) to arrange assessment.
What does the treatment cost?
Nothing. Program B.147 is fully funded by NFZ, covering esketamine (Spravato) nasal spray sessions with post-dose medical observation for up to 34 weeks.
How long is the wait?
Per NFZ data (as of June 2026), the first available date was 2026-06-30 with no queue and an average wait of 0 days.
1 more verified providers within 50 km
- Choroszcz · 12 kmSamodzielny Publiczny Psychiatryczny Zakład Opieki Zdrowotnej Im. Dr. Stanisława Deresza W Choroszczy : Spravato®
Practical details
As stated on the provider's own website (checked 2026-09-22); details can change — confirm when you book.
- BookingReferral required — the provider states access runs via a clinician's referral. Source →
Verification
- License / registryNFZ B.147
- Official registryhttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84&provider=Uniwersytecki%20Szpital%20Kliniczny%20W%20Bia%C5%82ymstoku&format=json
- Last verified
Check your fit & enquire
Check my fit & enquireWhat to prepare before you enquire
- A referral or the contact details of your treating clinician
- A list of medications you have tried (names, doses, duration)
- A short diagnosis summary or discharge letters